tiprankstipranks
Advertisement
Advertisement

SRZN Stock Latest News

Patrick Dolezal Reiterates Buy on Surrozen, Keeps Price Target Unchanged at $44 Ahead of Key BRUNELLO Readout
RatingsPatrick Dolezal Reiterates Buy on Surrozen, Keeps Price Target Unchanged at $44 Ahead of Key BRUNELLO Readout
11d ago
SRZN
Surrozen Shareholders Support Board, Auditor and Pay Policies
PremiumCompany Announcements
Surrozen Shareholders Support Board, Auditor and Pay Policies
3M ago
8K
SRZN
Surrozen price target raised to $44 from $36 at H.C. Wainwright
PremiumThe Fly
Surrozen price target raised to $44 from $36 at H.C. Wainwright
3M ago
SRZN
Surrozen Earns Buy Rating on Advancing Retinal Pipeline, Strong Cash Runway, and Large wAMD/DME Market Opportunity
PremiumRatings
Surrozen Earns Buy Rating on Advancing Retinal Pipeline, Strong Cash Runway, and Large wAMD/DME Market Opportunity
3M ago
SRZN
Surrozen reports Q1 EPS ($11.65) vs. ($7.43) last year
PremiumThe Fly
Surrozen reports Q1 EPS ($11.65) vs. ($7.43) last year
3M ago
SRZN
Surrozen management to meet with Cantor
PremiumThe FlySurrozen management to meet with Cantor
3M ago
SRZN
Surrozen: Buy Rating Reiterated as Analyst Highlights Wnt-Targeted Ophthalmology Strategy and Maintains $37 Price Target
Premium
Ratings
Surrozen: Buy Rating Reiterated as Analyst Highlights Wnt-Targeted Ophthalmology Strategy and Maintains $37 Price Target
3M ago
SRZN
Surrozen initiated with a Buy at TD Cowen
Premium
The Fly
Surrozen initiated with a Buy at TD Cowen
3M ago
SRZN
Surrozen price target raised to $36 from $32 at H.C. Wainwright
PremiumThe Fly
Surrozen price target raised to $36 from $32 at H.C. Wainwright
4M ago
SRZN
Surrozen files $200M mixed securities shelf
PremiumThe Fly
Surrozen files $200M mixed securities shelf
4M ago
SRZN
Surrozen, Inc. (SRZN) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Surrozen, Inc. (SRZN) Q4 Earnings Cheat Sheet
5M ago
SRZN
Surrozen initiated with an Overweight at Cantor Fitzgerald
PremiumThe Fly
Surrozen initiated with an Overweight at Cantor Fitzgerald
5M ago
SRZN
Surrozen announces routine board resignation with no disputes
PremiumCompany AnnouncementsSurrozen announces routine board resignation with no disputes
6M ago
8K
SRZN
Surrozen’s Innovative Wnt-Targeted Therapies Poised to Disrupt $15 Billion Anti-VEGF Market: A Compelling Buy Recommendation
Premium
Ratings
Surrozen’s Innovative Wnt-Targeted Therapies Poised to Disrupt $15 Billion Anti-VEGF Market: A Compelling Buy Recommendation
9M ago
SRZN
Surrozen initiated with an Outperform at LifeSci Capital
Premium
The Fly
Surrozen initiated with an Outperform at LifeSci Capital
9M ago
SRZN
Surrozen, Inc. Reports Significant Q3 2025 Loss
PremiumCompany Announcements
Surrozen, Inc. Reports Significant Q3 2025 Loss
9M ago
SRZN
Surrozen’s Innovative Wnt Pathway Advancements in Retinal Disease Treatment Earns Buy Rating
PremiumRatings
Surrozen’s Innovative Wnt Pathway Advancements in Retinal Disease Treatment Earns Buy Rating
9M ago
SRZN
Surrozen Appoints Andrew Maleki as New CFO
PremiumCompany Announcements
Surrozen Appoints Andrew Maleki as New CFO
9M ago
8K
SRZN
Surrozen names Andrew Maleki as CFO
PremiumThe Fly
Surrozen names Andrew Maleki as CFO
9M ago
SRZN
Surrozen’s Collaboration Agreement with TCGFB Terminated
PremiumCompany AnnouncementsSurrozen’s Collaboration Agreement with TCGFB Terminated
10M ago
8K
SRZN
Surrozen Signs $50M Sales Agreement with TD Securities
Premium
Company Announcements
Surrozen Signs $50M Sales Agreement with TD Securities
11M ago
8K
SRZN
Surrozen’s Innovative Wnt Pathway Approach Garners Buy Rating Amid Promising Preclinical Data
Premium
Ratings
Surrozen’s Innovative Wnt Pathway Approach Garners Buy Rating Amid Promising Preclinical Data
12M ago
SRZN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >